-
bitterly, brain, campaigners, concussion, disappointed, injury, League, News, Premier, rejected, substitution, temporary, trial
Brain injury campaigners ‘bitterly disappointed’ as Premier League temporary concussion substitution trial rejected | UK News
admin
Brain injury campaigners say they are “bitterly disappointed” after global football bosses rejected calls to hold a trial of temporary concussion substitutes in the Premier League next season. The International Football Association Board (IFAB) met at Wembley to discuss the possibility of a trial after a request from world players’ union FIFPRO and the World…
-
Elon Musk and Tesla going on trial over claims his tweets cost investors billions of dollars | Science & Tech News
admin
Elon Musk and Tesla are set to go on trial over allegations that shareholders were defrauded out of billions of dollars by his tweets. The company’s chief executive wrote in 2018 that he had “secured” funding to take the electric carmaker private and later that investor backing was “confirmed”, causing shares to soar and then…
-
areas, beam, broadband, Elon, government, highspeed, Musks, News, Remote, satellites, Science, Starlink, Tech, trial
Starlink: Elon Musk’s satellites to beam high-speed broadband to remote areas of UK in government trial | Science & Tech News
admin
Elon Musk’s Starlink satellites will be used in a UK government trial aimed at helping remote areas of the country get high-speed internet connections. Three locations will have the equipment installed to begin with, allowing them to link up to the satellites and access broadband 10 times faster than previously available. The technology allows broadband…
-
Hope for people with untreatable high blood pressure after trial on new drug Baxdrostat | Science & Tech News
admin
Researchers claim to have found a way to tackle previously untreatable high blood pressure. Scientists from Queen Mary University of London and the US pharmaceutical firm CinCor examined whether patients would benefit from taking a drug called Baxdrostat. Those who took a new medicine during a clinical trial were found to have significantly lower blood…
-
Lab-grown red blood cells transfused into patient in world-first clinical trial | Science & Tech News
admin
Laboratory-grown red blood cells have been transfused into a person in a world-first clinical trial. If proved safe and effective, manufactured blood cells could revolutionise treatments for people with blood disorders such as sickle cell and rare blood types. It can be hard to find well-matched donated blood for many with these disorders – and…
-
‘Historic moment’ in Alzheimer’s treatment as trial drug found to slow cognitive decline | Science & Tech News
admin
A new drug found to reduce cognitive decline in early-stage Alzheimer’s has been hailed as an “historic moment” in the treatment of the disease. During trials, Lecanemab was found to slow the decline in people’s memory and thinking by up to 27% over 18 months, compared with a placebo. Alzheimer’s Research UK called the finding…
-
asteroid, defence, Earth, miles, million, NASA, News, planetary, Science, smashes, spacecraft, Tech, trial
NASA smashes spacecraft into asteroid seven million miles from Earth in ‘planetary defence’ trial | Science & Tech News
admin
NASA has successfully smashed a spacecraft into an asteroid seven million miles from Earth. The last image from the “vending machine-sized” collider showed the surface of the asteroid Dimorphos seconds before impact. The Double Asteroid Redirection Test (DART) is the first-ever trial of a “planetary defence system”. If the orbit of an asteroid can be…
-
44bn, complete, deal, Elon, force, Musk, News, October, Science, set, showdown, takeover, Tech, trial, Twitter, tycoon
Twitter and Elon Musk set for October showdown trial as it tries to force tycoon to complete $44bn takeover deal | Science & Tech News
admin
Elon Musk’s bid to delay Twitter’s lawsuit against him until 2023 has been rejected by a US judge who granted the social media giant a fast-track trial. The world’s richest man said he was pulling out of a deal this month to buy the tech firm for $44bn (£36.6bn), and the company is suing him…